Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients

  • Nephrology – Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality in end-stage renal disease (ESRD), approximating a 10- to 20-fold higher risk of death in dialysis patients than in the general population. Despite this, dialysis patients often undergo fewer investigations, receive less invasive procedures, and are prescribed fewer medications compared with age-matched non-ESRD patients. A lack of randomized control trials for evidence-based treatment strategies in this population may explain some of these discrepancies, but there is concern that an attitude of “therapeutic nihilism” may be impacting on the medical care of these patients. In this review, we will explore CVD in the ESRD population. Specifically, we will try to address the following issues in patients with ESRD: (1) mechanisms of CVD, (2) cardiac evaluation and the role of coronary revascularization with percutaneous or coronary artery bypass procedures, and (3) cardiac pharmacotherapy use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. 2001 Report (2001) Volume 1: Dialysis and renal transplantation, Canadian Organ Replacement Register, Canadian Institute for Health Information, Ottawa, Ontario

  2. Foley N, Parfrey P, Sarnak M (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5):S112–S119

    Article  CAS  PubMed  Google Scholar 

  3. USRDS (2006) Annual data report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD

  4. United States Renal Data Systems: USRDS (2004) Annual data report. US Department of Health and Human Services. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

  5. Kendrick J, Chonchol MB (2008) Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Practice Nephrol 4:672–681

    Article  Google Scholar 

  6. Rigatto C (2003) Clinical epidemiology of cardiac disease in renal transplant recipients. Semin Dial 16:106–110

    Article  PubMed  Google Scholar 

  7. Parfrey PS, Foley RN, Harnett JD et al (1996) Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428–1434

    Article  CAS  PubMed  Google Scholar 

  8. Kasiske BL, Guijarro C, Massy ZA et al (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158–165

    CAS  PubMed  Google Scholar 

  9. Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985–992

    Article  CAS  PubMed  Google Scholar 

  10. Aakhus S, Dahl K, Wideroe TE (1999) Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 14:648–654

    Article  CAS  PubMed  Google Scholar 

  11. Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154–2169

    Article  PubMed  Google Scholar 

  12. Kasiske B, Harini C, Roel J (2000) Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11:1735–1743

    CAS  PubMed  Google Scholar 

  13. Ducloux D, Kazory A, Chalopin JM (2004) Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 66:441–447

    Article  PubMed  Google Scholar 

  14. Aine AEG, Margreiter R et al. (1992) Report on management of renal failure in Europe: XXII. Nephrol Dial Transplant Suppl 2:7–35

  15. Wanner C, Krane V, Marz W et al (2005) 4D: Atorvastatin in patients with Type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238–248

    Article  CAS  PubMed  Google Scholar 

  16. Fellstrom BC, Jardine AG, Schmieder RE et al (2009) AURORA: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360:1395–1407

    Article  CAS  PubMed  Google Scholar 

  17. Holdaas H, Fellstrom B, Jardine AG et al (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial. Lancet 361:2024–2031

    Article  CAS  PubMed  Google Scholar 

  18. Kramer H, Toto R, Peshock R et al (2005) Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol 16:507–513

    Article  PubMed  Google Scholar 

  19. Wexler L, Brundage B, Crouse J et al (1996) Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications: A statement for health professionals from the American Heart Association. Writing Group. Circulation 94:1175–1192

    CAS  PubMed  Google Scholar 

  20. Braun J, Oldendorf M, Moshage W et al (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401

    Article  CAS  PubMed  Google Scholar 

  21. Gelev S, Spasovski G, Dzikova S et al (2008) Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol 40:763–767

    Article  CAS  PubMed  Google Scholar 

  22. Moe SM, Chen NX (2008) Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19:213–216

    Article  CAS  PubMed  Google Scholar 

  23. London GM, Marchais SJ, Guérin AP et al (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827–1835

    Article  CAS  PubMed  Google Scholar 

  24. Block GA, Raggi P, Bellasi A et al (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438–441

    Article  CAS  PubMed  Google Scholar 

  25. Bleyer AJ, Hartman J, Brannon PC et al (2006) Characteristics of sudden death in hemodialysis patients. Kidney Int 69:2268–2273

    Article  CAS  PubMed  Google Scholar 

  26. Cheung AK, Sarnak MJ, Guofen Y et al (2004) Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO study. Kidney Int 65:2380–2389

    Article  PubMed  Google Scholar 

  27. Ritz E, Wanner C (2008) The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 3:920–929

    Article  PubMed  Google Scholar 

  28. Genovesi S, Valsecchi MG, Rossi E et al (2009) Sudden death and associated risk factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant 24:2529–2536

    Article  PubMed  Google Scholar 

  29. Snideman AD, Solhpour A, Alam A et al (2010) Cardiovascular death in dialysis patients: Lessons we can learn from AURORA. Clin J Am Soc Nephrol 5:335–340

    Article  Google Scholar 

  30. Kurella M, Covinsky KE, Collins AJ et al (2007) Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146:177–183

    PubMed  Google Scholar 

  31. Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799–805

    Article  CAS  PubMed  Google Scholar 

  32. Chertow GM, Normand SL, Silva LR et al (2000) Survival after acute myocardial infarction in patients with end-stage renal disease; results from the cooperative cardiovascular project. Am J Kidney Dis 35:1044–1051

    Article  CAS  PubMed  Google Scholar 

  33. US Renal Data System. USRDS (2002) Annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Disease

  34. Winkelmayer WC, Charytan DM, Levin R et al (2006) Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis 47:301–308

    Article  PubMed  Google Scholar 

  35. Shlipak MG, Heidenreich PA, Noguchi H et al (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555–562

    PubMed  Google Scholar 

  36. Keough-Ryan TM, Kiberd BA, Dipchand CS et al (2005) Outcomes of acute coronary syndrome in a large Canadian cohort: Impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 46:845–855

    Article  PubMed  Google Scholar 

  37. Hemmelgarm BR, Southern D, Culleton BF et al (2004) Survival after coronary revascularization among patients with kidney disease. Circulation 110:1890–1895

    Article  Google Scholar 

  38. Charytan D, Mauri L, Agarwal A et al (2006) The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J 152:558–564

    Article  PubMed  Google Scholar 

  39. Herzog CA, Littrell K, Arko C et al (2007) Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: A collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116:1465–1472

    Article  PubMed  Google Scholar 

  40. Herzog CA, Ma JZ, Collins AJ (2002) Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106:2207–2211

    Article  PubMed  Google Scholar 

  41. Charytan DM, Kuntz RE (2007) Risks of coronary artery bypass surgery in dialysis-dependent patients—analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant 22:1665–1671

    Article  PubMed  Google Scholar 

  42. Zhong H, David T, Zhang AH et al (2009) Coronary artery bypass grafting in patients on maintenance dialysis: is peritoneal dialysis a risk factor of operative mortality? Int Urol Nephrol 41:653–662

    Article  PubMed  Google Scholar 

  43. Herzog CA, Strief JW, Collins AJ et al (2008) Cause-specific mortality of dialysis patients after coronary revascularization: why don’t dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant 23:2629–2633

    Article  PubMed  Google Scholar 

  44. Sunagawa G, Komiya T, Tamura N et al (2010) Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg 89:1896–1900

    Article  PubMed  Google Scholar 

  45. Rubenstein MH, Harrell LC, Sheynberg BV et al (2000) Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Curculation 102:2966–2972

    CAS  Google Scholar 

  46. Nevis IF, Mathew A, Novick RJ et al (2009) Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol 4:369–378

    PubMed  Google Scholar 

  47. Trespalacios FC, Taylor AJ, Agodoa LY et al (2002) Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 62:1799–1805

    Article  PubMed  Google Scholar 

  48. Mason NA, Bailie GR, Satayathum S et al (2004) HMG-Coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 45:119–126

    Article  Google Scholar 

  49. Berger AK, Duval S, Krumholz HM (2003) Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42:201–208

    Article  CAS  PubMed  Google Scholar 

  50. Miller LM, Hopman WM, Garland JS et al (2006) Cardioprotective medication use in hemodialysis patients. Can J Cardiol 22:755–760

    PubMed  Google Scholar 

  51. Seliger SL, Stehman-Breen CO (2003) Are HMG-CoA reductase inhibitors underutilized in dialysis patient? Semin Dial 16:179–185

    Article  PubMed  Google Scholar 

  52. Harris K, Thomas M, Short C et al (2002) Assessment of the efficiency of treatment of dyslipidaemia in renal outpatients. J Nephrol 15:263–269

    PubMed  Google Scholar 

  53. Austin PC, Tu JV, Ko DT et al (2008) Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. CMAJ 179:895–900

    PubMed  Google Scholar 

  54. Paraskevas KI (2008) Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering. Int Urol Nephrol 40:165–170

    Article  CAS  PubMed  Google Scholar 

  55. Cook WL, Tomlinson G, Donaldson M et al (2006) Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol 1:1197–1204

    Article  PubMed  Google Scholar 

  56. Desmet C, Beguin C, Swine C, Jadoul M, The Universite Catholique de Louvain Collaborative Group (2005) Falls in hemodialysis patients: prospective study of incidence, risk factors, and complications. Am J Kidney Dis 45:148–153

    Article  PubMed  Google Scholar 

  57. Holden RM, Harman GJ, Wang M et al (2008) Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 3:105–110

    Article  PubMed  Google Scholar 

  58. Schech S, Graham D, Staffa J et al (2007) Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf 16:352–358

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Health Sciences Centre, GE-441, 820 Sherbrook St, Winnipeg, MB, R3A 1R9, Canada

    Lisa M. Miller & Joe Bueti

  2. Department of Medicine, St Boniface General Hospital, Winnipeg, MB, Canada

    Manish M. Sood, Martina Reslerova, Paul Komenda & Claudio Rigatto

  3. Department of Pharmacy, St Boniface General Hospital, Winnipeg, MB, Canada

    Amy R. Sood

Authors
  1. Lisa M. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manish M. Sood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amy R. Sood
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martina Reslerova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paul Komenda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudio Rigatto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joe Bueti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa M. Miller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, L.M., Sood, M.M., Sood, A.R. et al. Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Int Urol Nephrol 42, 1007–1014 (2010). https://doi.org/10.1007/s11255-010-9857-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-010-9857-x

Keywords

Search

Navigation